Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lara Bessa Campelo Pinheiro Cavalcante
Observed name:
L. B. C. P. Cavalcante
Institution:
Universidade Federal do Rio de Janeiro
Observed institutions:
Universidade Federal do Rio de Janeiro,
Universidade de São Paulo,
Hospital Universitário Clementino Fraga Filho,
Fleury S.A. (Brazil)
ORCID:
0000-0001-6289-3172
Observed ORCID:
0000-0001-6289-3172
OpenAlex ID:
A5070814753
Big data-based parathyroid hormone (PTH) values emphasize need for age correction
2023
·
L. B. C. P. Cavalcante
, C. M. Á. Brandão
, et al.
·
Journal of Endocrinological Investigation
·
22
PDF
High accuracy of bilateral and simultaneous petrosal sinus sampling with desmopressin for the differential diagnosis of pediatric ACTH-dependent Cushing’s syndrome
2020
·
Lara Bessa Campelo Pinheiro Cavalcante
, Thais Castanheira Freitas
, et al.
·
Pituitary
·
15
Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer
2024
·
Marise Codeco de Andrade Barreto
, Natalia Treistman
, et al.
·
European Thyroid Journal
·
6
PDF
Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients
2023
·
Natália Treistman
, Lara Bessa Campelo Pinheiro Cavalcante
, et al.
·
Endocrine
·
6
Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates
2024
·
Marise Codeco de Andrade Barreto
, Natalia Treistman
, et al.
·
Archives of Endocrinology and Metabolism
·
2
PDF
External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long‐term local disease control?
2024
·
Lara Bessa Campelo Pinheiro Cavalcante
, Natalia Treistman
, et al.
·
Head & Neck
·
2
Show more works
View as search
Works count:
6
Citation count:
53
H-index:
4
I10-index:
2
Year
Topic
Type